Neal Augenstein’s 3-Year Stage 4 Lung Cancer Survivorship Milestone: Targeted Therapy and Biomarker Testing Fuel Hope
WTOP's Neal Augenstein shares 3-year stage 4 lung cancer survivorship update, crediting…
Breakthrough Histone Modifications Research Reveals New Targets for Cancer Therapies
Memorial Sloan Kettering researchers unveil how histone modifications drive cancer gene regulation,…
Breakthrough in Histone Modifications: MSKCC Study Illuminates Gene Regulation and Cell Differentiation Pathways
Memorial Sloan Kettering researchers uncover how histone modifications regulate gene expression in…
DeepMind’s AlphaFold Upgrade Surpasses Human Protein Folding Expertise, Boosting Drug Discovery for Cancer and Beyond
Google DeepMind's AlphaFold 3 AI model predicts protein structures faster and more…
